• 1

    Wold, W.S. and Toth, K., Adenovirus vectors for gene therapy, vaccination and cancer gene therapy, Curr. Gene Ther., 2013, vol. 13, pp. 421–433.

  • 2

    He, T.C., Zhou, S., da Costa, L.T., Yu, J., Kinzler, K.W., and Vogelstein, B., A simplified system for generating recombinant adenoviruses, Proc. Natl. Acad. Sci. U. S. A., 1998, vol. 95, pp. 2509–2514.

  • 3

    Luo, J., Deng, Z.L., Luo, X., Tang, N., Song, W.X., Chen, J., et al., A protocol for rapid generation of recombinant adenoviruses using the AdEasy system, Nat. Protoc., 2007, vol. 2, pp. 1236–1247.

  • 4

    Zeng, M., Smith, S.K., Siegel, F., Shi, Z., Van Kampen, K.R., Elmets, C.A., et al., AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination, BioTechniques, 2001, vol. 31, pp. 260–262.

  • 5

    Miravet, S., Ontiveros, M., Piedra, J., Penalva, C., Monfar, M., and Chillon, M., Construction, production, and purification of recombinant adenovirus vectors, Methods Mol. Biol., 2014, vol. 1089, pp. 159–173.

  • 6

    Reddy, P.S., Ganesh, S., Hawkins, L., and Idamakanti, N., Generation of recombinant adenovirus using the Escherichia coli BJ5183 recombination system, Methods Mol. Med., 2007, vol. 130, pp. 61–68.

  • 7

    Wedeken, L., Ohnheiser, J., Hirschi, B., Wethkamp, N., and Klempnauer, K.H., Association of tumor suppressor protein Pdcd with ribosomes is mediated by protein-protein and protein-RNA interactions, Genes Cancer, 2010, vol. 1, pp. 293–301.

  • 8

    Cotteret, S. and Chernoff, J., Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties, Mol. Cell. Biol., 2006, vol. 26, pp. 3215–3230.

  • 9

    Titus, D.E., Promega Protocols and Applications Guide,Madison, WI: Promega Corp., 1991.

  • 10

    Shepelev, M.V., Chernoff, J., and Korobko, I.V., Rho family GTPase Chp/RhoV induces PC12 apoptotic cell death via JNK activation, Small GTPases, 2011, vol. 2, pp. 17–26.



  • Source link